---
title: "Soleno Therapeutics Inc — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7
json: https://whiteintel.dev/api/public/dossier/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7
identifier: gb-coh:SLNO
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Soleno Therapeutics Inc

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:SLNO`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7  

## Ownership & control

### Holdings / subsidiaries

- **SOLENO THERAPEUTICS UK LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/711aaa13-7df6-5068-8500-996d5acf90c0

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Soleno Therapeutics Inc**. Human view: https://whiteintel.dev/entity/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7 · Structured JSON: https://whiteintel.dev/api/public/dossier/ca18c9c5-e8d6-4405-9a7d-b15d5db3a3d7._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._